Literature DB >> 25324241

Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan".

L Joseph Wheat1, M Hong Nguyen2, Barbara D Alexander3, David Denning4, Angela M Caliendo5, G Marshall Lyon6, Lindsey R Baden7, Francisco M Marty7, Cornelius Clancy2, Emily Kirsch8, Pamela Noth8, John Witt8, Michele Sugrue9, John R Wingard9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25324241      PMCID： PMC4313270          DOI： 10.1128/JCM.02433-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  2 in total

1.  Insufficient demonstration of long-term stability of Aspergillus galactomannan.

Authors:  Gemma L Johnson; Shah-Jalal Sarker; Stephen A Bustin; Samir G Agrawal
Journal:  J Clin Microbiol       Date:  2014-11       Impact factor: 5.948

2.  Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.

Authors:  L Joseph Wheat; M Hong Nguyen; Barbara D Alexander; David Denning; Angela M Caliendo; G Marshall Lyon; Lindsey R Baden; Francisco M Marty; Cornelius Clancy; Emily Kirsch; Pamela Noth; John Witt; Michele Sugrue; John R Wingard
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948
  2 in total
  3 in total

1.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

2.  Importance of operational factors in the reproducibility of Aspergillus galactomannan enzyme immune assay.

Authors:  Nicolas Guigue; Samuel Lardeux; Alexandre Alanio; Samia Hamane; Marc Tabouret; Stéphane Bretagne
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

3.  Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?

Authors:  John R Wingard; Barbara D Alexander; Lindsey R Baden; Min Chen; Michele W Sugrue; Helen L Leather; Angela M Caliendo; Cornelius J Clancy; David W Denning; Francisco M Marty; M Hong Nguyen; L Joseph Wheat; Brent R Logan; Mary M Horowitz; Kieren A Marr
Journal:  Open Forum Infect Dis       Date:  2021-09-09       Impact factor: 3.835
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.